All articles published by MDPI are made immediately available worldwide under an open access license. No special
permission is required to reuse all or part of the article published by MDPI, including figures and tables. For
articles published under an open access Creative Common CC BY license, any part of the article may be reused without
permission provided that the original article is clearly cited. For more information, please refer to
https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature
Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for
future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive
positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
Editors select a small number of articles recently published in the journal that they believe will be particularly
interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the
most exciting work published in the various research areas of the journal.
We are pleased to announce the winners of the Antibiotics 2022 Best Paper Award. All papers published from 1 January 2022 to 31 December 2022 in Antibiotics were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, two winners were selected.
One Review: Antimicrobial Susceptibility Testing: A Comprehensive Review of Currently Used Methods By Ina Gajic, Jovana Kabic, Dusan Kekic, Milos Jovicevic, Marina Milenkovic, Dragana Mitic Culafic, Anika Trudic, Lazar Ranin and Natasa Opavski Antibiotics2022, 11(4), 427; doi: https://doi.org/10.3390/antibiotics11040427
One Article: Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy By Guillaume Loeuille, Elise D’Huart, Jean Vigneron, Yann-Eric Nisse, Benoit Beiler, Caroline Polo, Gillian Ayari, Matthieu Sacrez, Béatrice Demoré and Alexandre Charmillon Antibiotics2022, 11(4), 458; doi: https://doi.org/10.3390/antibiotics11040458
Each winner will receive CHF 500 and a chance to publish a paper in Antibiotics in 2024 after peer review.
Please join us in congratulating the winners of the Antibiotics 2022 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Antibiotics.
Kind regards, Antibiotics Editorial Office
Antibiotics 2022 Best Paper Award
Eligibility and Requirements
– All papers published in Antibodies will be eligible (Both regular and Special Issue submissions).
by
José Weverton Almeida-Bezerra, Saulo Almeida Menezes, José Thyálisson da Costa Silva, Simone Galdino de Sousa, Daniel Sampaio Alves, Gabriel Gonçalves Alencar, Isaac Moura Araújo, Ewerton Yago de Sousa Rodrigues, Cícera Datiane de Morais Oliveira-Tintino, Rafael Pereira da Cruz, Janaína Esmeraldo Rocha, Saulo Relison Tintino, José Maria Barbosa-Filho, Maria Flaviana Bezerra Morais-Braga, Irwin Rose Alencar de Menezes, António Raposo and Henrique Douglas Melo Coutinho
Synthetic Biology Center, Massachusetts Institute of Technology (MIT)
Philip Joosten
Veterinary Epidemiology Unit, Department of Obstetrics, Reproduction and Herd Health, Faculty of Veterinary Medicine, Ghent University
Winner
Eunice Ego Mgbeahuruike
Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, FI-00014 Helsinki, Finland
Bernardo Ribeiro da Cunha
Institute for Bioengineering and Biosciences (IBB), Instituto Superior Técnico (IST), Universidade de Lisboa (UL); Av. Rovisco Pais, 1049-001 Lisboa, Portugal
Award Committee
Prof. Nicholas Dixon
Chairperson
University of Wollongong
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.